SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
210 hedge funds and large institutions have $2.22B invested in Sage Therapeutics in 2023 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 75 increasing their positions, 54 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.71% more ownership
Funds ownership: 86.8% → 88.51% (+1.7%)
7% less capital invested
Capital invested by funds: $2.39B → $2.22B (-$170M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
210
Holding in Top 10
2
Calls
$16.2M
Puts
$8.11M
Top Buyers
| 1 | +$22.3M | |
| 2 | +$20.1M | |
| 3 | +$14.1M | |
| 4 |
Millennium Management
New York
|
+$11.8M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$10.5M |
Top Sellers
| 1 | -$473M | |
| 2 | -$26.7M | |
| 3 | -$8.81M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$8.41M |
| 5 |
D.E. Shaw & Co
New York
|
-$5.93M |